Emmanuel Benjamin Walter Jr.
Professor of Pediatrics
Dr. Emmanuel Walter, MD, MPH, Professor of Pediatrics, serves as the Duke Human Vaccine Institute (DHVI) Chief Medical Officer and directs the Duke Vaccine and Trials Unit. In these roles, Dr. Walter provides strategic and operational leadership for clinical research conducted at the Institute. In addition, he provides oversight of regulatory compliance for DHVI clinical research activities.
Dr. Walter has dedicated his career to advancing research and clinical practice in vaccinology, infectious diseases, and child health. He currently serves as the principal investigator for the Duke Clinical Core of the Collaborative Influenza Vaccine Innovations Centers (CIVICs) funded by the National Institute of Allergy and Infectious Diseases (NIAID). The goal of this work is to evaluate promising next generation influenza vaccine candidates in Phase I and Phase I/II clinical trials and human challenge studies. He is also the Duke Principal Investigator for the CDC-funded Clinical Immunization Safety Assessment Project which conducts studies to identify risk factors and preventive strategies for adverse events following immunization, particularly in special populations. Lastly, he is the Principal Investigator for the CDC-funded coordinating center of the influenza and other respiratory virus vaccine effectiveness network. This work provides national estimates for influenza and other respiratory virus vaccine effectiveness in persons presenting with respiratory illness in the ambulatory setting.
Dr. Walter's focused area of interest include vaccine development, vaccine safety, vacc9je effectiveness, vaccine coverage, prevention and treatment of infectious diseases.
Current Appointments & Affiliations
- Professor of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health, Pediatrics 2009
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1987
- Member of the Duke Human Vaccine Institute, Duke Human Vaccine Institute, Institutes and Centers 2013
- Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2020
Contact Information
- 27 Alexandria Way Box 106008, Dvtu @Rtp 3rd Floor Bldg. 3 Node, Durham, NC 27703
- Duke University PO Box 106008, Durham, NC 27710-6008
-
walte002@mc.duke.edu
(919) 620-5346
- Background
-
Education, Training, & Certifications
- M.P.H., University of North Carolina - Chapel Hill 1992
- M.D., University of Maryland, Baltimore 1983
- B.S., University of Notre Dame 1979
-
Medical Licensure
- 31677. North Carolina. 2023
-
Previous Appointments & Affiliations
- Associate Professor of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health, Pediatrics 2002 - 2009
- Associate Professor of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health, Pediatrics 1998 - 2002
- Assistant Professor of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health, Pediatrics 1992 - 1998
- Associate in the Department of Pediatrics, Pediatrics, Clinical Science Departments 1990 - 1992
- Recognition
-
In the News
-
MAR 30, 2021 Duke Health News -
NOV 6, 2020 School of Medicine -
OCT 21, 2020 -
AUG 20, 2020 Duke Health News -
MAR 25, 2020 Duke Health News -
SEP 30, 2019 Duke Health News -
JUN 19, 2015 Duke Today -
JUN 19, 2015 -
SEP 26, 2013 -
SEP 26, 2013 Duke Today
-
- Research
-
Selected Grants
- US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings awarded by Centers for Disease Control and Prevention 2022 - 2027
- CIVICs Component C -Option 13 Equitable Adj #2 awarded by National Institutes of Health 2021 - 2026
- CIVICs C (75N93019C00054) Option 14 awarded by National Institutes of Health 2022 - 2026
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program awarded by University of North Carolina - Chapel Hill 2016 - 2026
- Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program awarded by National Institutes of Health 2021 - 2026
- CIVICs Component C - Option 13A.1 Equitable Adjustment awarded by National Institutes of Health 2020 - 2025
- CIVICS Component C - Option 13A awarded by National Institutes of Health 2019 - 2025
- Immunogenicity and risk of autoimmune cross-reactivity of COVID-19 mRNA vaccines in SLE - RRF Investigator Award awarded by Rheumatology Research Foundation 2022 - 2025
- Duke Women's Reproductive Health Research Scholars awarded by National Institutes of Health 2020 - 2025
- Lead Site Optional Task 1: Babies COVID-19 Vaccination awarded by Centers for Disease Control and Prevention 2022 - 2024
- CISA COVID Flu Immunogenicity awarded by Centers for Disease Control and Prevention 2022 - 2024
- CISA 10-Pediatric COVID-19 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2021 - 2024
- MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BIVALENT BNT162b2 RNA-BASED VACCINE CANDIDATE IN HEALTHY CHILDREN awarded by Pfizer, Inc. 2022 - 2024
- VTEU 14-0053 Task C Option 2 Protocol Implementation awarded by National Institutes of Health 2018 - 2024
- VTEU: Task Area D: Research Laboratory Analysis Protocol #14-0053 awarded by National Institutes of Health 2015 - 2024
- COVID-19 Adaptive VAriant Immunologic Landscape Trial or COVAIL Trial awarded by Leidos Biomedical Research, Inc. 2022 - 2023
- CIVICS Component C - Option 8 B.1 awarded by National Institutes of Health 2021 - 2023
- CIVICS Component C - Option 8 awarded by National Institutes of Health 2020 - 2023
- VTEU 14-0053 Task C Option 4 Protocol Implementation awarded by National Institutes of Health 2019 - 2023
- VTEU 14-0053 Task C Option 3 Protocol Implementation awarded by National Institutes of Health 2015 - 2023
- 2020 CISA 04-COVID Maternal Study awarded by Centers for Disease Control and Prevention 2020 - 2023
- CISA Consult 2022 Contributing Task 1 awarded by Centers for Disease Control and Prevention 2022 - 2023
- CISA Consult 2022 Contributing Task 3 awarded by Centers for Disease Control and Prevention 2022 - 2023
- CIVICS Component C - Option 3 awarded by National Institutes of Health 2019 - 2023
- VTEU Sample Task Orders awarded by National Institutes of Health 2013 - 2023
- Vaccine and Treatment Evaluation Units (VTEU) awarded by National Institutes of Health 2013 - 2023
- Lead Site Task 4: Simultaneous RZV and all V4 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2022 - 2023
- Lead Site Task 5: Simultaneous RZV and all V4 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2022 - 2023
- Lead Site Task 6: Simultaneous RZV and all V4 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2022 - 2023
- CIVICS Component A - Option 3 awarded by National Institutes of Health 2019 - 2023
- CIVICS Component C - Option 9 awarded by National Institutes of Health 2020 - 2023
- VTEU TO #132 Base - Task Area A - FY.2020.A1B1C1D1.0123 - Option 2.A awarded by National Institutes of Health 2021 - 2023
- Yellow Fever Vaccine Trial - U44 Clinical Trial with Najit awarded by Najit Technologies, Inc. 2021 - 2023
- A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 awarded by Pfizer, Inc. 2021 - 2023
- HVTN 3002 Protocol Funding (PF) - Durham Protocol-Specific Site awarded by Fred Hutchinson Cancer Research Center 2020 - 2023
- VTEU 13-0053 FY 2020 Option 1-Protocol Implementation awarded by National Institutes of Health 2014 - 2023
- EHR Surveillance of Lower Respiratory Tract (LRTI) and Respiratory Syncytial Virus (RSV) LRTI in Infants awarded by Clinetic, Inc 2022 - 2023
- A PHASE 1, OPEN-LABEL DOSE-FINDING AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY CHILDREN 5 TO 12 YEARS OF AGE awarded by Pfizer, Inc. 2021 - 2023
- EPCTU - Task Area A - Admin and Overall awarded by National Institutes of Health 2022 - 2023
- A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER BLIND, DOSE-FINDING STUDY TO DESCRIBE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND POTENTIAL EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINS awarded by Pfizer, Inc. 2020 - 2022
- VTEU 18-0010.B1C1.0120_Task C Option 1 awarded by National Institutes of Health 2019 - 2022
- Task Area B-D Task Order 16-0058.B1C1D1.0076 awarded by National Institutes of Health 2017 - 2022
- VACCINE AND TREATMENT EVALUATION UNITS (VTEU) PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA B-D PHASE 1 PK TRIAL TO EVALUATE FOSFOMYCIN TASK ORDER 16-0058.B1C1D1.0076 awarded by National Institutes of Health 2017 - 2022
- VTEU Task D Option 1 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2022
- VTEU Task D Option 2 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2022
- VTEU Task D Option 3 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2022
- VTEU Task D Option 4 Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2022
- CISA 07 Adult RCT COVID-19 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2020 - 2022
- IMPAACT PTCL 17 Trial awarded by Johns Hopkins University 2018 - 2022
- CISA 2021-2022 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2020 - 2022
- CISA 2021-2022 - Clinical Consult - Base awarded by Centers for Disease Control and Prevention 2020 - 2022
- Clinical Vaccine Safety Evaluation - Contributing Site - Task COVID - Optional Task 3 awarded by Centers for Disease Control and Prevention 2020 - 2022
- CISA 2017 06 - Clinical Consult - Base awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2017 06 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2018-2019 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2017 - 2022
- CISA 2018-2019 - Clinical Consult - Base awarded by Centers for Disease Control and Prevention 2017 - 2022
- CIVICS Component C - Option 16 awarded by National Institutes of Health 2019 - 2022
- CISA Lead Site Task 3: Simultaneous RVZ and all V4 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2021 - 2022
- RTOP 2018 CISA 01 Flublok Lead Task 2 awarded by Centers for Disease Control and Prevention 2020 - 2022
- RTOP 2018 CISA 01 Flublok Lead Task 3 awarded by Centers for Disease Control and Prevention 2020 - 2022
- RTOP 2018 CISA 01 Flublok Lead Task 4 awarded by Centers for Disease Control and Prevention 2020 - 2022
- CISA RTOP 2017-01 Apnea (Lead) - Option 2 awarded by Centers for Disease Control and Prevention 2019 - 2022
- RTOP 2018 CISA 01 Flublok Lead Base awarded by Centers for Disease Control and Prevention 2018 - 2022
- RTOP 2018 CISA 01 Flublok Lead Task 1 awarded by Centers for Disease Control and Prevention 2018 - 2022
- "An adaptive prenatal (ADEPT) intervention to encourage childhood vaccinations awarded by Centers for Disease Control and Prevention 2021 - 2022
- Reducing disparities in adolescent HPV vaccination coverage in the Carolinas awarded by Centers for Disease Control and Prevention 2018 - 2022
- CISA RFTP Syncope Prevention Study (Lead) 2020-2022 awarded by Centers for Disease Control and Prevention 2020 - 2022
- CISA Shingrix 2020 Lead Site Task 2 awarded by Centers for Disease Control and Prevention 2020 - 2022
- VTEU Task Order 22 16-0058 - Cost to Complete awarded by National Institutes of Health 2021 - 2022
- VTEU Task Order 16-0058.B1C1D1.0076 - Task D awarded by National Institutes of Health 2017 - 2022
- Lead Site Task 1: Simultaneous RZV and all V4 Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2020 - 2021
- Adaptive COVID-19 Treatment Trial (ACTT) awarded by Leidos Biomedical Research, Inc. 2020 - 2021
- RFTP 2018 CISA 05 FLUAD Logical Follow On Task 1 awarded by Centers for Disease Control and Prevention 2018 - 2021
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Option 1 awarded by National Institutes of Health 2020 - 2021
- VTEU Protocol Implementation Option 1 awarded by National Institutes of Health 2019 - 2021
- VTEU RTOP FY.2017.B8C12.0080 - Task B awarded by National Institutes of Health 2017 - 2021
- VTEU Task C Option 2 Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2017 - 2021
- CISA RTOP 2017-01 Apnea (Lead) - Option 1 awarded by Centers for Disease Control and Prevention 2017 - 2021
- IMPAACT 2021 Core funding PTCL 11 awarded by Johns Hopkins University 2019 - 2020
- CISA: 2015 CISA 02 - Contributing Site Base Task: Consultation for the LAIV and Asthma Study (Contributing) awarded by Centers for Disease Control and Prevention 2015 - 2020
- CISA: 2015 CISA 02 - Contributing Site Optional Task 1: Enrollment and Data Collection for the LAIV and Asthma Study (Contributing) awarded by Centers for Disease Control and Prevention 2015 - 2020
- CISA 2018-2019 - Clinical Consult - Opt 2 awarded by Centers for Disease Control and Prevention 2019 - 2020
- VTEU Task D Protocol FY.2015.D1B1C1.0032 awarded by National Institutes of Health 2015 - 2020
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base awarded by National Institutes of Health 2019 - 2020
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base-A awarded by National Institutes of Health 2019 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 1 awarded by National Institutes of Health 2017 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 3 awarded by National Institutes of Health 2017 - 2020
- VTEU RTOP FY.2017.B8C12.0080 - Task C - Option 8 awarded by National Institutes of Health 2017 - 2020
- VTEU Task Area D Option 9 Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2017 - 2020
- VTEU Task Area C Option 3 Protocol FY.2016.C1.0026 awarded by National Institutes of Health 2016 - 2020
- VAC057: Assess the reactogenicity, safety, and immunogenicity of a live attenuated universal influenza vaccine awarded by PATH 2017 - 2020
- IMPAACT Trial--13 CF awarded by Johns Hopkins University 2018 - 2019
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Option 2 awarded by Centers for Disease Control and Prevention 2018 - 2019
- RFTP 2016 CISA 01 - Base - FLUAD vs. Fluzone® High-Dose Study (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2019
- VTEU 18-0010.B1C1.0120_Task B Base awarded by National Institutes of Health 2019
- VTEU 14-0053 Task Area A Project Logistics and Site Activation awarded by National Institutes of Health 2018 - 2019
- VTEU: Task Area C: Protocol Implementation - Option 2 Protocol #14-0053 awarded by National Institutes of Health 2015 - 2019
- VTEU Task Order 18-0011.B1.C1.0116-Task B Base awarded by National Institutes of Health 2018 - 2019
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base awarded by National Institutes of Health 2018 - 2019
- VTEU Task C Option 1 Protocol 15-0066.B1C1D1.0041 awarded by National Institutes of Health 2016 - 2019
- VTEU Task Area D Option 8B Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2016 - 2019
- VTEU Task B Base Protocol 15-0066.B1C1D1.0041 awarded by National Institutes of Health 2016 - 2018
- IMPAACT trial awarded by Johns Hopkins University 2018
- VTEU Task Area D Option 8 Protocol FY.2016.D1.0026 awarded by National Institutes of Health 2016 - 2018
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Base awarded by Centers for Disease Control and Prevention 2017 - 2018
- CISA RFTP 2017-03 Syncope Prevention Study (Lead) - Option 1 awarded by Centers for Disease Control and Prevention 2017 - 2018
- CISA: 2015 CISA 03 - Lead Site Optional Task 1 (Combined Options 1-11): Additional Subjects for Maternal Tdap and IIV Study (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2018
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead) awarded by Centers for Disease Control and Prevention 2015 - 2018
- CISA RTOP 2017-01 Apnea (Lead) - Base awarded by Centers for Disease Control and Prevention 2017 - 2018
- RFTP 2016 CISA 03 - Option 1 - Fever after Simultaneous Vaccination (Lead) awarded by Centers for Disease Control and Prevention 2017 - 2018
- VTEU Task Area C Option 3B Protocol FY.2016.C1.0026 awarded by National Institutes of Health 2016 - 2018
- VTEU FY.2018.A1B1C1D1.0077 - Task A - Option 1 awarded by National Institutes of Health 2017 - 2018
- VTEU FY.2018.A1B1C1D1.0077 Task Area A - Base awarded by National Institutes of Health 2017 - 2018
- VTEU Task B Option 2 - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2017 - 2018
- VTEU Task C Option 1 Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2016 - 2018
- VTEU Task Order 16-0047 -Task C Option 1 awarded by National Institutes of Health 2018
- VTEU Task Order 16-0047.C1.0090 awarded by National Institutes of Health 2018
- A Double-Blind, Randomized, Placebo-controlled, Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001, in Healthy Adults awarded by National Institutes of Health 2014 - 2018
- VTEU: Base -Task Area A: Project Logistics and Site Activation Protocol #14-0053 awarded by National Institutes of Health 2015 - 2017
- RFTP 2016 CISA 03 - Base - Fever after simultaneous vaccination (Lead) awarded by Centers for Disease Control and Prevention 2016 - 2017
- VTEU Task Area B Option 2 Protocol FY.2016.B1.0026 awarded by National Institutes of Health 2016 - 2017
- CISA Clinical Consult TO I - Option 4 awarded by Centers for Disease Control and Prevention 2016 - 2017
- CISA Task Order No. 3 Tdap Safety in Pregnant Women Infant Option Task 1-CLIN0002 awarded by Centers for Disease Control and Prevention 2014 - 2017
- VTEU Task A Option 1 - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2017
- VTEU Task A Base - FY.2017.A1B1C1D1.0048 awarded by National Institutes of Health 2016 - 2017
- CISA Task Order No. 3 Tdap Safety in Pregnant Women Infant Option Task 2-CLIN0003 awarded by Centers for Disease Control and Prevention 2014 - 2017
- VTEU Task Area B Option 2 Protocol FY.2016.B1.0026 awarded by National Institutes of Health 2016 - 2017
- VTEU Task B Base Protocol 14-0079.B1C1.0028 awarded by National Institutes of Health 2015 - 2016
- Option Three (3) of Contract No. 200-2012-53663, Task Order 0001 awarded by Centers for Disease Control and Prevention 2015 - 2016
- CISA TO2 Prophylactic Antipyretics Revision 1-A awarded by Centers for Disease Control and Prevention 2014 - 2016
- CISA TO2 Prophylactic Antipyretics Revision 3-A awarded by Centers for Disease Control and Prevention 2014 - 2016
- CISA Task Order No. 3 Tdap Safety in Pregnant Women awarded by Centers for Disease Control and Prevention 2013 - 2016
- VTEU Task A Protocol FY.2015.A4D14.0033 awarded by National Institutes of Health 2015 - 2016
- Subcontract: Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention awarded by Carolinas HealthCare System 2013 - 2016
- CISA TO2 Prophylactic Antipyretics awarded by Centers for Disease Control and Prevention 2013 - 2016
- VTEU Task Area A, Base Protocol FY.2016.A1.0026 awarded by National Institutes of Health 2015 - 2016
- VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053 awarded by National Institutes of Health 2015 - 2016
- Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
- Multiscale Systems Immunology awarded by National Institutes of Health 2010 - 2015
- VTEU Task Area A - FY.2015.A1.0016 Base awarded by National Institutes of Health 2014 - 2015
- Clinical Trial Services Agreement with bioCSL to Study the Performance of CSL Trivalent Influenza Vaccine awarded by ACCELOVANCE, INC. 2014 - 2015
- VTEU 12-0016: Task Area C: Protocol implementation awarded by National Institutes of Health 2014 - 2015
- VTEU 13-0053 Task Area B: Phase I, single dose, open-label, parallel group study comparing the pharmacokinetics and safety of PA-824 in subjects with mild, moderate, and severe hepatic impairment to matched, normal, healthy subjects. awarded by National Institutes of Health 2014 - 2015
- CISA-Task Order 1: Option 1 awarded by Centers for Disease Control and Prevention 2013 - 2014
- CISA awarded by Centers for Disease Control and Prevention 2012 - 2013
- SAFETY AND IMMUNOGENICITY OF TDAP VACCINE IN HEALTHY PREGNANT WOMEN, SAFETY IN THEIR NEONATES, AND EFFECT OF MATERNAL IMMUNIZATION ON INFANT IMMUNE RESPONSES TO DTAP VACCINE - DMID 05-0048 awarded by University of Maryland 2010 - 2012
- Effectiveness of a Vaccination Program in the Community ObGyn Setting awarded by Centers for Disease Control and Prevention 2008 - 2011
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant women. awarded by University of Maryland 2009 - 2010
- Prevention of Influenza in Infants by Immunization of Their Contacts in the Household (PIIITCH study) awarded by Centers for Disease Control and Prevention 2006 - 2009
- Preschool Vision Screening in Primary Care Settings awarded by National Institutes of Health 2003 - 2008
- Implementing Research Findings for Practice Improvement awarded by National Institutes of Health 2002 - 2006
- Epidemiologic Research Studies of AIDS and HIV Infection awarded by National Institutes of Health 1998 - 2000
- Epidemiologic Research Studies Of Aids And Hiv Infection awarded by National Institutes of Health 1995 - 1998
- Evaluation Of Perinatal Hiv Prevention In North Carolina awarded by National Institutes of Health 1995 - 1998
-
External Relationships
- American Academy of Pediatrics
- Clinetic
- College of Diplomates of the American Board of Pediatric Dentistry
- Iliad Biotechnologies
- Moderna Therapeutics, Inc.
- Najit Technologies
- Pfizer Inc.
- Sequiris
- Vaxcyte
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Ortiz, Justin R., David I. Bernstein, Daniel F. Hoft, Christopher W. Woods, Micah T. McClain, Sharon E. Frey, Rebecca C. Brady, et al. “A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults.” J Infect Dis, January 26, 2023. https://doi.org/10.1093/infdis/jiad021.Full Text Link to Item
-
Hemmersbach-Miller, Marion, Stephen J. Balevic, Patricia L. Winokur, Cornelia B. Landersdorfer, Kenan Gu, Austin W. Chan, Michael Cohen-Wolkowiez, et al. “Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan.” Clin Pharmacokinet, January 12, 2023. https://doi.org/10.1007/s40262-022-01198-z.Full Text Link to Item
-
Neuzil, Kathleen M., Evan J. Anderson, Robert W. Frenck, Sharon E. Frey, Emmanuel B. Walter, Richard Rupp, Elizabeth T. Rotrosen, et al. “Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.” Clin Infect Dis, January 5, 2023. https://doi.org/10.1093/cid/ciac982.Full Text Link to Item
-
Tsalik, Ephraim L., Nadine G. Rouphael, Ruxana T. Sadikot, Maria C. Rodriguez-Barradas, Micah T. McClain, Dana M. Wilkins, Christopher W. Woods, et al. “Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.” The Lancet. Infectious Diseases, December 2022, S1473-3099(22)00735-6. https://doi.org/10.1016/s1473-3099(22)00735-6.Full Text
-
Fish, Laura J., Sayward E. Harrison, Jodi-Ann McDonald, Valerie Yelverton, Charnetta Williams, Emmanuel B. Walter, and Lavanya Vasudevan. “Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in North and South Carolina.” Hum Vaccin Immunother 18, no. 5 (November 30, 2022): 2058264. https://doi.org/10.1080/21645515.2022.2058264.Full Text Link to Item
-
Kracalik, Ian, Matthew E. Oster, Karen R. Broder, Margaret M. Cortese, Maleeka Glover, Karen Shields, C Buddy Creech, et al. “Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.” Lancet Child Adolesc Health 6, no. 11 (November 2022): 788–98. https://doi.org/10.1016/S2352-4642(22)00244-9.Full Text Link to Item
-
Kwon, Jiye, Yong Kong, Martina Wade, Derek J. Williams, Clarence Buddy Creech, Scott Evans, Emmanuel B. Walter, et al. “Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia.” J Infect Dis 226, no. 6 (September 21, 2022): 1109–19. https://doi.org/10.1093/infdis/jiac082.Full Text Link to Item
-
Wolfe, Cameron R., Kay M. Tomashek, Thomas F. Patterson, Carlos A. Gomez, Vincent C. Marconi, Mamta K. Jain, Otto O. Yang, et al. “Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.” The Lancet. Respiratory Medicine 10, no. 9 (September 2022): 888–99. https://doi.org/10.1016/s2213-2600(22)00088-1.Full Text Open Access Copy
-
Vasudevan, Lavanya, Jan Ostermann, Yunfei Wang, Sayward E. Harrison, Valerie Yelverton, Laura J. Fish, Charnetta Williams, and Emmanuel B. Walter. “Association of caregiver attitudes with adolescent HPV vaccination in 13 southern US states.” Vaccine X 11 (August 2022): 100181. https://doi.org/10.1016/j.jvacx.2022.100181.Full Text Link to Item
-
Wang, Grace, Jack T. Stapleton, Arthur W. Baker, Nadine Rouphael, C Buddy Creech, Hana M. El Sahly, Jason E. Stout, et al. “Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections.” Open Forum Infect Dis 9, no. 8 (August 2022): ofac375. https://doi.org/10.1093/ofid/ofac375.Full Text Open Access Copy Link to Item
-
Branche, Angela R., Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, et al. “SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.” Medrxiv, July 15, 2022. https://doi.org/10.1101/2022.07.12.22277336.Full Text Link to Item
-
Pettigrew, M. M., J. Kwon, J. F. Gent, Y. Kong, M. Wade, D. J. Williams, C. B. Creech, et al. “Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia.” Mbio 13, no. 2 (April 26, 2022): e0019522. https://doi.org/10.1128/mbio.00195-22.Full Text Link to Item
-
Raja, S. M., J. T. Guptill, V. C. Juel, E. B. Walter, M. Cohen-Wolkowiez, H. Hill, E. Sendra, et al. “First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.” Antimicrob Agents Chemother 66, no. 4 (April 19, 2022): e0173221. https://doi.org/10.1128/aac.01732-21.Full Text Link to Item
-
See, Isaac, Allison Lale, Paige Marquez, Michael B. Streiff, Allison P. Wheeler, Naomi K. Tepper, Emily Jane Woo, et al. “Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.” Ann Intern Med 175, no. 4 (April 2022): 513–22. https://doi.org/10.7326/M21-4502.Full Text Link to Item
-
Sokolow, Andrew G., Amy P. Stallings, Carolyn Kercsmar, Theresa Harrington, Natalia Jimenez-Truque, Yuwei Zhu, Katherine Sokolow, et al. “Safety of Live Attenuated Influenza Vaccine in Children With Asthma.” Pediatrics 149, no. 4 (April 1, 2022). https://doi.org/10.1542/peds.2021-055432.Full Text Link to Item
-
Walter, Emmanuel B., and Michael J. Smith. “Prevention of pneumococcal infections in childhood: two decades of progress.” Curr Opin Pediatr 34, no. 2 (April 1, 2022): 140–46. https://doi.org/10.1097/MOP.0000000000001112.Full Text Link to Item
-
Walter, Emmanuel B., Kawsar R. Talaat, and Alejandra Gurtman. “More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med 386, no. 12 (March 24, 2022): 1192–93. https://doi.org/10.1056/NEJMc2201556.Full Text Link to Item
-
Greenberg, Rachel G., Cornelia B. Landersdorfer, Nazario Rivera-Chaparro, Melissa Harward, Thomas Conrad, Aya Nakamura, Carl M. Kirkpatrick, et al. “Population Pharmacokinetics of Moxifloxacin in Children.” Paediatr Drugs 24, no. 2 (March 2022): 163–73. https://doi.org/10.1007/s40272-022-00493-3.Full Text Link to Item
-
Williams, Derek J., C Buddy Creech, Emmanuel B. Walter, Judith M. Martin, Jeffrey S. Gerber, Jason G. Newland, Lee Howard, et al. “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.” Jama Pediatr 176, no. 3 (March 1, 2022): 253–61. https://doi.org/10.1001/jamapediatrics.2021.5547.Full Text Open Access Copy Link to Item
-
Walter, Emmanuel B., Kawsar R. Talaat, and Alejandra Gurtman. “BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med 386, no. 6 (February 10, 2022): 606. https://doi.org/10.1056/NEJMc2118775.Full Text Link to Item
-
Walter, Emmanuel B., Kawsar R. Talaat, Charu Sabharwal, Alejandra Gurtman, Stephen Lockhart, Grant C. Paulsen, Elizabeth D. Barnett, et al. “Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.” The New England Journal of Medicine 386, no. 1 (January 2022): 35–46. https://doi.org/10.1056/nejmoa2116298.Full Text
-
Vasudevan, Lavanya, Jan Ostermann, Yunfei Wang, Sayward E. Harrison, Valerie Yelverton, Jodi-Ann McDonald, Laura J. Fish, Charnetta Williams, and Emmanuel B. Walter. “Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.” Vaccine 39, no. 51 (December 17, 2021): 7485–93. https://doi.org/10.1016/j.vaccine.2021.10.036.Full Text Link to Item
-
Permar, Sallie, C Buddy Creech, Kathryn M. Edwards, and Emmanuel B. Walter. “Proposals to Accelerate Novel Vaccine Development for Children.” Pediatrics, December 10, 2021. https://doi.org/10.1542/peds.2021-054593.Full Text Link to Item
-
Kalil, Andre C., Aneesh K. Mehta, Thomas F. Patterson, Nathaniel Erdmann, Carlos A. Gomez, Mamta K. Jain, Cameron R. Wolfe, et al. “Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.” The Lancet. Respiratory Medicine 9, no. 12 (December 2021): 1365–76. https://doi.org/10.1016/s2213-2600(21)00384-2.Full Text
-
Messina, Julia A., Eileen K. Maziarz, John Galgiani, Jonathan T. Truong, Aung K. Htoo, Arash Heidari, Royce H. Johnson, et al. “A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever).” Contemporary Clinical Trials Communications 24 (December 2021): 100851. https://doi.org/10.1016/j.conctc.2021.100851.Full Text Open Access Copy
-
Hurst, Jillian H., Sarah M. Heston, Hailey N. Chambers, Hannah M. Cunningham, Meghan J. Price, Lilianna Suarez, Carter G. Crew, et al. “Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.” Clin Infect Dis 73, no. 9 (November 2, 2021): e2875–82. https://doi.org/10.1093/cid/ciaa1693.Full Text Open Access Copy Link to Item
-
Permar, Sallie, C Buddy Creech, Kathryn M. Edwards, and Emmanuel B. Walter. “Proposals to Accelerate Novel Vaccine Development for Children.” Pediatrics, October 22, 2021. https://doi.org/10.1542/peds.2021-054593.Full Text Link to Item
-
Harrison, Sayward E., Valerie Yelverton, Yunfei Wang, Jan Ostermann, Laura J. Fish, Charnetta L. Williams, Lavanya Vasudevan, and Emmanuel B. Walter. “Examining Associations between Knowledge and Vaccine Uptake Using the Human Papillomavirus Knowledge Questionnaire (HPV-KQ).” Am J Health Behav 45, no. 5 (September 30, 2021): 810–27. https://doi.org/10.5993/AJHB.45.5.2.Full Text Link to Item
-
Frenck, Robert W., Nicola P. Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L. Perez, et al. “Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.” The New England Journal of Medicine 385, no. 3 (July 2021): 239–50. https://doi.org/10.1056/nejmoa2107456.Full Text
-
Guptill, J. T., S. M. Raja, V. C. Juel, E. B. Walter, M. Cohen-Wolkowiez, H. Hill, E. Sendra, B. Hauser, P. Jackson, and G. K. Swamy. “Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.” Antimicrob Agents Chemother 65, no. 7 (June 17, 2021): e0232920. https://doi.org/10.1128/AAC.02329-20.Full Text Link to Item
-
Glenn, Dorey A., Anisha Hegde, Elizabeth Kotzen, Emmanuel B. Walter, Abhijit V. Kshirsagar, Ronald Falk, and Amy Mottl. “Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease.” Kidney Int Rep 6, no. 5 (May 2021): 1407–10. https://doi.org/10.1016/j.ekir.2021.02.011.Full Text Open Access Copy Link to Item
-
Abate, Getahun, Jack T. Stapleton, Nadine Rouphael, Buddy Creech, Jason E. Stout, Hana M. El Sahly, Lisa Jackson, et al. “Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease.” Clin Infect Dis 72, no. 7 (April 8, 2021): 1127–37. https://doi.org/10.1093/cid/ciaa252.Full Text Link to Item
-
Schmader, Kenneth E., Christine K. Liu, Theresa Harrington, Wes Rountree, Heidi Auerbach, Emmanuel B. Walter, Elizabeth D. Barnett, et al. “Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial.” Jama Netw Open 4, no. 1 (January 4, 2021): e2031266. https://doi.org/10.1001/jamanetworkopen.2020.31266.Full Text Link to Item
-
Nachbagauer, Raffael, Jodi Feser, Abdollah Naficy, David I. Bernstein, Jeffrey Guptill, Emmanuel B. Walter, Franceso Berlanda-Scorza, et al. “A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.” Nat Med 27, no. 1 (January 2021): 106–14. https://doi.org/10.1038/s41591-020-1118-7.Full Text Link to Item
-
Walter, Emmanuel B., and M Anthony Moody. “Vaccine Development: Steps to Approval of an Investigational Vaccine.” N C Med J 82, no. 2 (2021): 141–44. https://doi.org/10.18043/ncm.82.2.141.Full Text Link to Item
-
Beigel, John H., Kay M. Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, Andre C. Kalil, Elizabeth Hohmann, et al. “Remdesivir for the Treatment of Covid-19 - Final Report.” N Engl J Med 383, no. 19 (November 5, 2020): 1813–26. https://doi.org/10.1056/NEJMoa2007764.Full Text Link to Item
-
Jenks, Jennifer A., Cody S. Nelson, Hunter K. Roark, Matthew L. Goodwin, Robert F. Pass, David I. Bernstein, Emmanuel B. Walter, et al. “Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.” Sci Transl Med 12, no. 568 (November 4, 2020). https://doi.org/10.1126/scitranslmed.abb3611.Full Text Link to Item
-
Hurst, Jillian H., Sarah M. Heston, Hailey N. Chambers, Hannah M. Cunningham, Meghan J. Price, Liliana Suarez, Carter G. Crew, et al. “SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.” Medrxiv, September 1, 2020. https://doi.org/10.1101/2020.08.18.20166835.Full Text Open Access Copy Link to Item
-
Walter, Emmanuel B., and Robert L. Atmar. “Improving Influenza Prevention: Modest Changes With Large Effects.” Clin Infect Dis 70, no. 12 (June 10, 2020): 2503–4. https://doi.org/10.1093/cid/ciz683.Full Text Link to Item
-
Greenberg, Rachel G., Huali Wu, Anil Maharaj, Michael Cohen-Wolkowiez, Kay M. Tomashek, Blaire L. Osborn, Reese H. Clark, and Emmanuel B. Walter. “A Pharmacoepidemiologic Study of the Safety and Effectiveness of Clindamycin in Infants.” Pediatr Infect Dis J 39, no. 3 (March 2020): 204–10. https://doi.org/10.1097/INF.0000000000002524.Full Text Link to Item
-
Walter, Emmanuel B., Nicola P. Klein, A Patricia Wodi, Wes Rountree, Christopher A. Todd, Amy Wiesner, Jonathan Duffy, Paige L. Marquez, and Karen R. Broder. “Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations.” Pediatrics 145, no. 3 (March 2020). https://doi.org/10.1542/peds.2019-1909.Full Text Link to Item
-
Bernstein, David I., Jeffrey Guptill, Abdollah Naficy, Raffael Nachbagauer, Francesco Berlanda-Scorza, Jodi Feser, Patrick C. Wilson, et al. “Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.” Lancet Infect Dis 20, no. 1 (January 2020): 80–91. https://doi.org/10.1016/S1473-3099(19)30393-7.Full Text Link to Item
-
Keitel, W. A., D. C. Voronca, R. L. Atmar, S. Paust, H. Hill, M. C. Wolff, A. R. Bellamy, and A. R. VTEU H5N1 Vaccine Working Group. “Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.” Vaccine 37, no. 37 (September 3, 2019): 5535–43. https://doi.org/10.1016/j.vaccine.2019.04.066.Full Text Link to Item
-
Grohskopf, Lisa A., Elif Alyanak, Karen R. Broder, Emmanuel B. Walter, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.” Mmwr Recomm Rep 68, no. 3 (August 23, 2019): 1–21. https://doi.org/10.15585/mmwr.rr6803a1.Full Text Link to Item
-
Munoz, Flor M., Evan J. Anderson, David I. Bernstein, Christopher J. Harrison, Barbara Pahud, Edwin Anderson, C Buddy Creech, et al. “Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.” Vaccine 37, no. 36 (August 23, 2019): 5161–70. https://doi.org/10.1016/j.vaccine.2019.07.085.Full Text Link to Item
-
Hills, Susan L., Emmanuel B. Walter, Robert L. Atmar, Marc Fischer, and Marc ACIP Japanese Encephalitis Vaccine Work Group. “Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.” Mmwr Recomm Rep 68, no. 2 (July 19, 2019): 1–33. https://doi.org/10.15585/mmwr.rr6802a1.Full Text Link to Item
-
Woods, Christopher W., Ana M. Sanchez, Geeta K. Swamy, Micah T. McClain, Lynn Harrington, Debra Freeman, Elizabeth A. Poore, et al. “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.” Vaccine 37, no. 30 (July 9, 2019): 4222–30. https://doi.org/10.1016/j.vaccine.2018.12.026.Full Text Link to Item
-
Edwards, James M., Nora Watson, Chris Focht, Clara Wynn, Christopher A. Todd, Emmanuel B. Walter, R Phillips Heine, and Geeta K. Swamy. “Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.” Infect Dis Obstet Gynecol 2019 (2019): 5430493. https://doi.org/10.1155/2019/5430493.Full Text Open Access Copy Link to Item
-
Fortner, Kimberly B., Geeta K. Swamy, Karen R. Broder, Natalia Jimenez-Truque, Yuwei Zhu, Pedro L. Moro, Jennifer Liang, et al. “Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.” Vaccine 36, no. 42 (October 8, 2018): 6354–60. https://doi.org/10.1016/j.vaccine.2018.07.012.Full Text Link to Item
-
Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.” Mmwr Recomm Rep 67, no. 3 (August 24, 2018): 1–20. https://doi.org/10.15585/mmwr.rr6703a1.Full Text Link to Item
-
Brady, Rebecca C., Lisa A. Jackson, Sharon E. Frey, Andi L. Shane, Emmanuel B. Walter, Geeta K. Swamy, Elizabeth P. Schlaudecker, et al. “Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.” Vaccine 36, no. 31 (July 25, 2018): 4663–71. https://doi.org/10.1016/j.vaccine.2018.06.036.Full Text Link to Item
-
Grohskopf, Lisa A., Leslie Z. Sokolow, Alicia M. Fry, Emmanuel B. Walter, and Daniel B. Jernigan. “Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.” Mmwr Morb Mortal Wkly Rep 67, no. 22 (June 8, 2018): 643–45. https://doi.org/10.15585/mmwr.mm6722a5.Full Text Link to Item
-
Belongia, Edward A., Ruth A. Karron, Arthur Reingold, Emmanuel B. Walter, and Nancy M. Bennett. “The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.” Vaccine 36, no. 3 (January 8, 2018): 343–44. https://doi.org/10.1016/j.vaccine.2017.06.017.Full Text Link to Item
-
Walter, Emmanuel B., Christoph P. Hornik, Lisa Grohskopf, Charles E. McGee, Christopher A. Todd, Oidda I. Museru, Lynn Harrington, and Karen R. Broder. “The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.” Vaccine 35, no. 48 Pt B (December 4, 2017): 6664–71. https://doi.org/10.1016/j.vaccine.2017.10.020.Full Text Link to Item
-
Grohskopf, L. A., L. Z. Sokolow, K. R. Broder, E. B. Walter, J. S. Bresee, A. M. Fry, and D. B. Jernigan. “Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season.” Am J Transplant 17, no. 11 (November 2017): 2970–82. https://doi.org/10.1111/ajt.14511.Full Text Link to Item
-
Kemper, Alex R., Elizabeth D. Barnett, Emmanuel B. Walter, Christoph Hornik, Natalie Pierre-Joseph, Karen R. Broder, Michael Silverstein, and Theresa Harrington. “Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial.” Pediatrics 140, no. 5 (November 2017). https://doi.org/10.1542/peds.2017-0508.Full Text Link to Item
-
Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Joseph S. Bresee, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.” Mmwr Recomm Rep 66, no. 2 (August 25, 2017): 1–20. https://doi.org/10.15585/mmwr.rr6602a1.Full Text Link to Item
-
Grohskopf, Lisa A., Leslie Z. Sokolow, Karen R. Broder, Emmanuel B. Walter, Joseph S. Bresee, Alicia M. Fry, and Daniel B. Jernigan. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.” Mmwr Recommendations and Reports 66, no. 2 (August 25, 2017): 3–21.Link to Item
-
Saleh, Ezzeldin, Geeta K. Swamy, M Anthony Moody, and Emmanuel B. Walter. “Parental Approach to the Prevention and Management of Fever and Pain Following Childhood Immunizations: A Survey Study.” Clin Pediatr (Phila) 56, no. 5 (May 2017): 435–42. https://doi.org/10.1177/0009922816675116.Full Text Link to Item
-
Fuller, Jill E., Emmanuel B. Walter, Nancy Dole, Richard O’Hara, Amy H. Herring, Maureen S. Durkin, Bonny Specker, and Betty Wey. “State-Level Immunization Information Systems: Potential for Childhood Immunization Data Linkages.” Matern Child Health J 21, no. 1 (January 2017): 29–35. https://doi.org/10.1007/s10995-016-2090-1.Full Text Link to Item
-
Saleh, Ezzeldin, M Anthony Moody, and Emmanuel B. Walter. “Effect of antipyretic analgesics on immune responses to vaccination.” Hum Vaccin Immunother 12, no. 9 (September 2016): 2391–2402. https://doi.org/10.1080/21645515.2016.1183077.Full Text Link to Item
-
Walter, Emmanuel B., and Mary Allen Staat. “Rotavirus Vaccine and Intussusception Hospitalizations.” Pediatrics 138, no. 3 (September 2016). https://doi.org/10.1542/peds.2016-1952.Full Text Link to Item
-
Libster, Romina, Monica McNeal, Emmanuel B. Walter, Andi L. Shane, Patricia Winokur, Gretchen Cress, Andrea A. Berry, et al. “Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules.” Pediatrics 137, no. 2 (February 2016): e20152603. https://doi.org/10.1542/peds.2015-2603.Full Text Link to Item
-
Mbawuike, Innocent N., Robert L. Atmar, Shital M. Patel, David B. Corry, Patricia L. Winokur, Rebecca C. Brady, Wilbur H. Chen, et al. “Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.” Vaccine 34, no. 4 (January 20, 2016): 547–54. https://doi.org/10.1016/j.vaccine.2015.11.055.Full Text Link to Item
-
Weiss, Thomas, Dongmu Zhang, Nagesh N. Borse, and Emmanuel B. Walter. “Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009.” Vaccine 33, no. 48 (November 27, 2015): 6871–77. https://doi.org/10.1016/j.vaccine.2015.07.065.Full Text Link to Item
-
Winokur, Patricia L., Shital M. Patel, Rebecca Brady, Wilbur H. Chen, Samer S. El-Kamary, Kathryn Edwards, C Buddy Creech, et al. “Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.” J Infect Dis 212, no. 4 (August 15, 2015): 525–30. https://doi.org/10.1093/infdis/jiv087.Full Text Link to Item
-
Chung, Richard J., Emmanuel B. Walter, Alex R. Kemper, and Amanda Dayton. “Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina.” J Adolesc Health 56, no. 5 Suppl (May 2015): S14–16. https://doi.org/10.1016/j.jadohealth.2014.10.272.Full Text Link to Item
-
Russell, Kate, Eileen F. Dunne, Alex R. Kemper, Rowena J. Dolor, Elizabeth R. Unger, Gitika Panicker, Lauri E. Markowitz, and Emmanuel B. Walter. “Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals.” Vaccine 33, no. 16 (April 15, 2015): 1953–58. https://doi.org/10.1016/j.vaccine.2015.02.058.Full Text Link to Item
-
Walter, Emmanuel B., Alex R. Kemper, Rowena J. Dolor, and Eileen F. Dunne. “Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.” Pediatr Infect Dis J 34, no. 2 (February 2015): 200–202. https://doi.org/10.1097/INF.0000000000000537.Full Text Link to Item
-
Grohskopf, Lisa A., Sonja J. Olsen, Leslie Z. Sokolow, Joseph S. Bresee, Nancy J. Cox, Karen R. Broder, Ruth A. Karron, and Emmanuel B. Walter. “Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–15 Influenza Season.” American Journal of Transplantation 14, no. 12 (December 2014): 2906–13. https://doi.org/10.1111/ajt.13065.Full Text
-
Callahan, S Todd, Mark Wolff, Heather R. Hill, Kathryn M. Edwards, and Kathryn M. NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. “Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.” J Infect Dis 210, no. 8 (October 15, 2014): 1270–74. https://doi.org/10.1093/infdis/jiu245.Full Text Link to Item
-
Belshe, Robert B., Sharon E. Frey, Irene L. Graham, Edwin L. Anderson, Lisa A. Jackson, Paul Spearman, Srilatha Edupuganti, et al. “Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.” Jama 312, no. 14 (October 8, 2014): 1420–28. https://doi.org/10.1001/jama.2014.12609.Full Text Link to Item
-
Kepler, Thomas B., Hua-Xin Liao, S Munir Alam, Rekha Bhaskarabhatla, Ruijun Zhang, Chandri Yandava, Shelley Stewart, et al. “Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies.” Cell Host Microbe 16, no. 3 (September 10, 2014): 304–13. https://doi.org/10.1016/j.chom.2014.08.006.Full Text Link to Item
-
Grohskopf, Lisa A., Sonja J. Olsen, Leslie Z. Sokolow, Joseph S. Bresee, Nancy J. Cox, Karen R. Broder, Ruth A. Karron, Emmanuel B. Walter, and Emmanuel B. Centers for Disease Control and Prevention. “Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.” Mmwr Morb Mortal Wkly Rep 63, no. 32 (August 15, 2014): 691–97.Link to Item
-
Kotloff, Karen L., Natasha B. Halasa, Christopher J. Harrison, Janet A. Englund, Emmanuel B. Walter, James C. King, C Buddy Creech, et al. “Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.” Pediatr Infect Dis J 33, no. 8 (August 2014): 865–71. https://doi.org/10.1097/INF.0000000000000329.Full Text Link to Item
-
Jackson, Katherine J. L., Yi Liu, Krishna M. Roskin, Jacob Glanville, Ramona A. Hoh, Katie Seo, Eleanor L. Marshall, et al. “Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.” Cell Host Microbe 16, no. 1 (July 9, 2014): 105–14. https://doi.org/10.1016/j.chom.2014.05.013.Full Text Link to Item
-
Munoz, Flor M., Nanette H. Bond, Maurizio Maccato, Phillip Pinell, Hunter A. Hammill, Geeta K. Swamy, Emmanuel B. Walter, et al. “Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.” Jama 311, no. 17 (May 7, 2014): 1760–69. https://doi.org/10.1001/jama.2014.3633.Full Text Link to Item
-
Steiner, Brian, Geeta K. Swamy, and Emmanuel B. Walter. “Engaging expectant parents to receive Tdap vaccination.” Am J Perinatol 31, no. 5 (May 2014): 407–12. https://doi.org/10.1055/s-0033-1352483.Full Text Link to Item
-
Specker, Bonny, Betty Wey, Jill Fuller, Marie-Noel Sandoval, Maureen Durkin, Nancy Dole, and Emmanuel B. Walter. “2009 H1N1 and seasonal influenza immunization among pregnant women: a comparison of different sources of immunization information.” Matern Child Health J 18, no. 3 (April 2014): 681–87. https://doi.org/10.1007/s10995-013-1293-y.Full Text Link to Item
-
Munoz, F. M., N. H. Bond, M. Maccato, P. Pinell, H. A. Hammill, G. K. Swamy, E. B. Walter, et al. “Safety and immunogenicity of tetanus, diphtheria, and acellular pertussis immunization during pregnancy in mothers and infants: A randomized clinical trial.” Obstetrical and Gynecological Survey 69, no. 9 (January 1, 2014): 517–19. https://doi.org/10.1097/OGX.0000000000000101.Full Text
-
Walter, Emmanuel B., and Dennis A. Clements. “Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses?” Pediatrics 132, no. 2 (August 2013): e498–99. https://doi.org/10.1542/peds.2013-1573.Full Text Link to Item
-
Frey, Sharon E., Patricia L. Winokur, Robert A. Salata, Samer S. El-Kamary, Christine B. Turley, Emmanuel B. Walter, Christine Mhorag Hay, et al. “Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.” Vaccine 31, no. 29 (June 24, 2013): 3025–33. https://doi.org/10.1016/j.vaccine.2013.04.050.Full Text Link to Item
-
Walter, Emmanuel B., and Richard J. Chung. “Immunizations for preteens.” N C Med J 74, no. 1 (2013): 66–71.Link to Item
-
Chen, Wilbur H., Patricia L. Winokur, Kathryn M. Edwards, Lisa A. Jackson, Anna Wald, Emmanuel B. Walter, Diana L. Noah, Mark Wolff, Karen L. Kotloff, and Karen L. Pandemic H1N1 Vaccine Adult Study Group. “Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.” Vaccine 30, no. 28 (June 13, 2012): 4240–48. https://doi.org/10.1016/j.vaccine.2012.04.044.Full Text Link to Item
-
Dolinsky, Diana H., Sarah C. Armstrong, Emmanuel B. Walter, and Alex R. Kemper. “The effectiveness of a primary care-based pediatric obesity program.” Clin Pediatr (Phila) 51, no. 4 (April 2012): 345–53. https://doi.org/10.1177/0009922811425232.Full Text Link to Item
-
Hauber, A Brett, Robbin Itzler, F Reed Johnson, Ateesha F. Mohamed, Juan Marcos González, John R. Cook, and Emmanuel B. Walter. “Healthy-days time equivalents for outcomes of acute rotavirus infections.” Vaccine 29, no. 45 (October 19, 2011): 8086–93. https://doi.org/10.1016/j.vaccine.2011.08.041.Full Text Link to Item
-
Whittle, James R. R., Ruijun Zhang, Surender Khurana, Lisa R. King, Jody Manischewitz, Hana Golding, Philip R. Dormitzer, et al. “Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.” Proc Natl Acad Sci U S A 108, no. 34 (August 23, 2011): 14216–21. https://doi.org/10.1073/pnas.1111497108.Full Text Link to Item
-
Frenck, Robert W., Robert Belshe, Rebecca C. Brady, Patricia L. Winokur, James D. Campbell, John Treanor, Christine M. Hay, et al. “Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.” Vaccine 29, no. 34 (August 5, 2011): 5666–74. https://doi.org/10.1016/j.vaccine.2011.06.010.Full Text Link to Item
-
“A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011.” Pediatr Infect Dis J 30, no. 7 (July 2011): 606–7. https://doi.org/10.1097/INF.0b013e318224949e.Full Text Link to Item
-
Tan, Weiyi, Anthony J. Viera, Beth Rowe-West, Amy Grimshaw, Beth Quinn, and Emmanuel B. Walter. “The HPV vaccine: are dosing recommendations being followed?” Vaccine 29, no. 14 (March 21, 2011): 2548–54. https://doi.org/10.1016/j.vaccine.2011.01.066.Full Text Link to Item
-
Moody, M Anthony, Ruijun Zhang, Emmanuel B. Walter, Christopher W. Woods, Geoffrey S. Ginsburg, Micah T. McClain, Thomas N. Denny, et al. “H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.” Plos One 6, no. 10 (2011): e25797. https://doi.org/10.1371/journal.pone.0025797.Full Text Open Access Copy Link to Item
-
Walter, Emmanuel B., Nancy Dole, Anna Maria Siega-Riz, and Barbara Entwisle. “The National Children's Study in North Carolina: a study of the effect of the environment on children's health, growth, and development.” N C Med J 72, no. 2 (2011): 160–64.Link to Item
-
Kemper, A. R., E. Landolfo, and E. B. Walter. “Special considerations of medication adherence in childhood and adolescence,” December 1, 2010, 311–20. https://doi.org/10.1007/978-1-4419-5866-2_13.Full Text
-
Halperin, Scott A., Anil Gupta, Robert Jeanfreau, Nicola P. Klein, Keith Reisinger, Emmanuel Walter, Lisa Bedell, Christopher Gill, and Peter M. Dull. “Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.” Vaccine 28, no. 50 (November 23, 2010): 7865–72. https://doi.org/10.1016/j.vaccine.2010.09.092.Full Text Link to Item
-
Walter, Emmanuel B., Norma J. Allred, Geeta K. Swamy, Anne S. Hellkamp, and Rowena J. Dolor. “Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates.” Infect Control Hosp Epidemiol 31, no. 10 (October 2010): 1070–73. https://doi.org/10.1086/656563.Full Text Open Access Copy Link to Item
-
Walter, Emmanuel B., Shilpa Rajagopal, Yuwei Zhu, Kathleen M. Neuzil, Mary P. Fairchok, and Janet A. Englund. “Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?” Vaccine 28, no. 27 (June 17, 2010): 4376–83. https://doi.org/10.1016/j.vaccine.2010.04.058.Full Text Link to Item
-
Englund, Janet A., Emmanuel Walter, Steven Black, Mark Blatter, Jack Nyberg, Frederick L. Ruben, Michael D. Decker, and Michael D. GRC28 Study Team. “Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.” Pediatr Infect Dis J 29, no. 2 (February 2010): 105–10. https://doi.org/10.1097/INF.0b013e3181b84c34.Full Text Link to Item
-
Mast, T Christopher, Emmanuel B. Walter, Monique Bulotsky, Shazia S. Khawaja, Daniel J. DiStefano, Mary K. Sandquist, Walter L. Straus, and Mary Allen Staat. “Burden of childhood rotavirus disease on health systems in the United States.” Pediatr Infect Dis J 29, no. 2 (February 2010): e19–25. https://doi.org/10.1097/inf.0b013e3181ca7e2e.Full Text Link to Item
-
Walter, Emmanuel B., Janet A. Englund, Mark Blatter, Jack Nyberg, Frederick L. Ruben, Michael D. Decker, and Michael D. GRC27 Study Team. “Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.” Pediatr Infect Dis J 28, no. 12 (December 2009): 1099–1104. https://doi.org/10.1097/INF.0b013e3181b0c0ca.Full Text Link to Item
-
Liao, Hua-Xin, Marc C. Levesque, Ashleigh Nagel, Ashlyn Dixon, Ruijun Zhang, Emmanuel Walter, Robert Parks, et al. “High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.” J Virol Methods 158, no. 1–2 (June 2009): 171–79. https://doi.org/10.1016/j.jviromet.2009.02.014.Full Text Link to Item
-
Mast, T Christopher, Carla DeMuro-Mercon, Claudia M. Kelly, Leigh Ellen Floyd, and Emmanuel B. Walter. “The impact of rotavirus gastroenteritis on the family.” Bmc Pediatr 9 (February 6, 2009): 11. https://doi.org/10.1186/1471-2431-9-11.Full Text Link to Item
-
Walter, Emmanuel B., Norma Allred, Beth Rowe-West, Kathlene Chmielewski, Katrina Kretsinger, and Rowena J. Dolor. “Cocooning infants: Tdap immunization for new parents in the pediatric office.” Acad Pediatr 9, no. 5 (2009): 344–47. https://doi.org/10.1016/j.acap.2009.05.027.Full Text Link to Item
-
Keitel, Wendy A., James D. Campbell, John J. Treanor, Emmanuel B. Walter, Shital M. Patel, Fenhua He, Diana L. Noah, and Heather Hill. “Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.” J Infect Dis 198, no. 9 (November 1, 2008): 1309–16. https://doi.org/10.1086/592172.Full Text Link to Item
-
Walter, Emmanuel B., Martha A. Snyder, Dennis A. Clements, and Samuel L. Katz. “Large injection site reactions after a second dose of varicella vaccine.” Pediatr Infect Dis J 27, no. 8 (August 2008): 757–59. https://doi.org/10.1097/INF.0b013e31816fc323.Full Text Link to Item
-
Talbot, H Keipp, Wendy Keitel, Thomas R. Cate, John Treanor, James Campbell, Rebecca C. Brady, Irene Graham, et al. “Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.” Vaccine 26, no. 32 (July 29, 2008): 4057–61. https://doi.org/10.1016/j.vaccine.2008.05.024.Full Text Link to Item
-
Walter, E. B., A. S. Hellkamp, K. C. Goldberg, D. Montgomery, B. Patterson, and R. J. Dolor. “Improving influenza vaccine coverage among asthmatics: A practice-based research network study.” Journal of Clinical Outcomes Management 15, no. 5 (May 1, 2008): 227–34.
-
Walter, E. B., H. Yang, and R. J. Dolor. “Low rates of adherence to 1999 acute otitis media treatment guidelines across pediatric and family practices.” Journal of Clinical Outcomes Management 14, no. 11 (November 1, 2007): 595–600.
-
Guerra, Fernando A., Jacqueline Gress, Alan Werzberger, Keith Reisinger, Emmanuel Walter, Hassan Lakkis, Anthony D. Grosso, Carolee Welebob, Barbara J. Kuter, and Barbara J. Pediatric Study Group for VAQTA. “Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.” Pediatr Infect Dis J 25, no. 10 (October 2006): 912–19. https://doi.org/10.1097/01.inf.0000238135.01287.b9.Full Text Link to Item
-
Englund, Janet A., Emmanuel B. Walter, Adepeju Gbadebo, Arnold S. Monto, Yuwei Zhu, and Kathleen M. Neuzil. “Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.” Pediatrics 118, no. 3 (September 2006): e579–85. https://doi.org/10.1542/peds.2006-0201.Full Text Link to Item
-
Walter, Emmanuel B., Kathleen M. Neuzil, Yuwei Zhu, Mary P. Fairchok, Martha E. Gagliano, Arnold S. Monto, and Janet A. Englund. “Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?” Pediatrics 118, no. 3 (September 2006): e570–78. https://doi.org/10.1542/peds.2006-0198.Full Text Link to Item
-
Stout, J. E., T. Ostbye, E. B. Walter, and C. D. Hamilton. “Tuberculosis knowledge and attitudes among physicians who treat young children in North Carolina, USA.” Int J Tuberc Lung Dis 10, no. 7 (July 2006): 783–88.Link to Item
-
Green, Michael D., Bernard Beall, Mario J. Marcon, Coburn H. Allen, John S. Bradley, Barry Dashefsky, Janet R. Gilsdorf, et al. “Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.” J Antimicrob Chemother 57, no. 6 (June 2006): 1240–43. https://doi.org/10.1093/jac/dkl101.Full Text Link to Item
-
Kuter, Barbara J., Michelle L Hoffman Brown, Jonathan Hartzel, Wendy R. Williams, A. EvesiKaren, Steve Black, Henry Shinefield, et al. “Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).” Hum Vaccin 2, no. 5 (2006): 205–14. https://doi.org/10.4161/hv.2.5.3246.Full Text Link to Item
-
Green, Michael, Coburn Allen, John Bradley, Barry Dashefsky, Janet R. Gilsdorf, Mario J. Marcon, Gordon E. Schutze, et al. “In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.” Antimicrob Agents Chemother 49, no. 6 (June 2005): 2487–89. https://doi.org/10.1128/AAC.49.6.2487-2489.2005.Full Text Link to Item
-
Englund, Janet A., Emmanuel B. Walter, Mary P. Fairchok, Arnold S. Monto, and Kathleen M. Neuzil. “A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.” Pediatrics 115, no. 4 (April 2005): 1039–47. https://doi.org/10.1542/peds.2004-2373.Full Text Link to Item
-
Friedman, Joëlle Y., Shelby D. Reed, Kevin P. Weinfurt, Kristijan H. Kahler, Emmanuel B. Walter, and Kevin A. Schulman. “Parents' reported preference scores for childhood atopic dermatitis disease states.” Bmc Pediatr 4, no. 1 (October 18, 2004): 21. https://doi.org/10.1186/1471-2431-4-21.Full Text Link to Item
-
Blaney, Nancy T., M Isabel Fernandez, Kathleen A. Ethier, Tracey E. Wilson, Emmanuel Walter, Linda J. Koenig, and Linda J. Perinatal Guidelines Evaluation Project Group. “Psychosocial and behavioral correlates of depression among HIV-infected pregnant women.” Aids Patient Care Stds 18, no. 7 (July 2004): 405–15. https://doi.org/10.1089/1087291041518201.Full Text Link to Item
-
Benjamin, D. K., W. C. Miller, R. W. Ryder, D. J. Weber, E. Walter, and R. E. McKinney. “Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings.” Aids Patient Care Stds 18, no. 1 (January 2004): 35–43. https://doi.org/10.1089/108729104322740901.Full Text Link to Item
-
Benjamin, Daniel K., Wiliam C. Miller, Robert W. Ryder, David J. Weber, Emmanuel Walter, and Ross E. McKinney. “A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.” Aids 17, no. 16 (November 7, 2003): 2331–36. https://doi.org/10.1097/00002030-200311070-00007.Full Text Link to Item
-
Wilson, Tracey E., Linda J. Koenig, Emmanual Walter, Isabel Fernandez, Kathleen Ethier, and Kathleen Perinatal Guidelines Evaluation Project. “Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: the importance of an event-level focus for promoting safer sexual behaviors.” Sex Transm Dis 30, no. 11 (November 2003): 809–12. https://doi.org/10.1097/01.OLQ.0000086617.41012.14.Full Text Link to Item
-
Clark, H Fred, Carl J. Burke, David B. Volkin, Paul Offit, Richard L. Ward, Joseph S. Bresee, Penelope Dennehy, et al. “Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.” Pediatr Infect Dis J 22, no. 10 (October 2003): 914–20. https://doi.org/10.1097/01.inf.0000091887.48999.77.Full Text Link to Item
-
Wilson, Tracey E., Linda Koenig, Jeannette Ickovics, Emmanuel Walter, Amy Suss, M Isabel Fernandez, and M Isabel Perinatal Guidelines Evaluation Project. “Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states.” J Acquir Immune Defic Syndr 33, no. 5 (August 15, 2003): 608–13. https://doi.org/10.1097/00126334-200308150-00010.Full Text Link to Item
-
Parnes, Curt, Judith Guillermin, Rolf Habersang, Peggy Nicholes, Vijay Chawla, Tammy Kelly, Judith Fishbein, et al. “Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.” Pediatr Pulmonol 35, no. 6 (June 2003): 484–89. https://doi.org/10.1002/ppul.10288.Full Text Link to Item
-
Royce, R. A., E. B. Walter, M. I. Fernandez, T. E. Wilson, J. R. Ickovics, R. J. Simonds, and R. J. Perinatal Guidelines Evaluation Project. “Barriers to universal prenatal HIV testing in 4 US locations in 1997.” Am J Public Health 91, no. 5 (May 2001): 727–33. https://doi.org/10.2105/ajph.91.5.727.Full Text Link to Item
-
Wilson, T. E., J. R. Ickovics, M. I. Fernandez, L. J. Koenig, E. Walter, and E. Perinatal Guidelines Evaluation Project. “Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states.” Am J Obstet Gynecol 184, no. 6 (May 2001): 1235–40. https://doi.org/10.1067/mob.2001.114032.Full Text Link to Item
-
Clements, D. A., J. I. Zaref, C. L. Bland, E. B. Walter, and P. M. Coplan. “Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina.” Arch Pediatr Adolesc Med 155, no. 4 (April 2001): 455–61. https://doi.org/10.1001/archpedi.155.4.455.Full Text Link to Item
-
Walter, E. B., R. A. Royce, M. I. Fernández, J. DeHovitz, J. R. Ickovics, M. A. Lampe, and M. A. Perinatal Guidelines Evaluation Project group. “New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection.” Obstet Gynecol 97, no. 1 (January 2001): 70–76. https://doi.org/10.1016/s0029-7844(00)01070-x.Full Text Link to Item
-
Ickovics, J. R., K. A. Ethier, L. J. Koenig, T. E. Wilson, E. B. Walter, and M. I. Fernandez. “Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors.” Health Psychol 19, no. 6 (November 2000): 515–23. https://doi.org/10.1037//0278-6133.19.6.515.Full Text Link to Item
-
Frey, S., R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, H. Kollaritsch, M. H. Mazur, et al. “Reply.” J Infect Dis 182, no. 3 (September 2000): 1005–6. https://doi.org/10.1086/315793.Full Text Link to Item
-
Napravnik, S., R. Royce, E. Walter, and W. Lim. “HIV-1 infected women and prenatal care utilization: barriers and facilitators.” Aids Patient Care Stds 14, no. 8 (August 2000): 411–20. https://doi.org/10.1089/108729100416623.Full Text Link to Item
-
Clements, D. A., J. I. Zaref, P. M. Coplan, C. L. Bland, and E. B. Walter. “Decreased incidence of varicella in day care children after the initiation of varicella vaccination: A herd immunity effect?” Clinical Infectious Diseases 31, no. 1 (July 1, 2000): 323–323.Link to Item
-
Abraham, B., D. Parenti, S. Frey, R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, et al. “Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine [1] (multiple letters).” Journal of Infectious Diseases 182, no. 3 (2000): 1005–6.
-
Fernández, M. I., T. E. Wilson, K. A. Ethier, E. B. Walter, C. L. Gay, and J. Moore. “Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project.” Public Health Rep 115, no. 5 (2000): 460–68. https://doi.org/10.1093/phr/115.5.460.Full Text Link to Item
-
Clements, D. A., S. P. Moreira, P. M. Coplan, C. L. Bland, and E. B. Walter. “Postlicensure study of varicella vaccine effectiveness in a day-care setting.” Pediatr Infect Dis J 18, no. 12 (December 1999): 1047–50. https://doi.org/10.1097/00006454-199912000-00004.Full Text Link to Item
-
Frey, S., R. Dagan, Y. Ashur, X. Q. Chen, J. Ibarra, H. Kollaritsch, M. H. Mazur, et al. “Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.” J Infect Dis 180, no. 6 (December 1999): 2018–22. https://doi.org/10.1086/315119.Full Text Link to Item
-
Walter, E. B., R. B. Hornick, G. A. Poland, R. Tucker, C. L. Bland, D. A. Clements, C. C. Rhamstine, et al. “Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults.” Vaccine 17, no. 11–12 (March 17, 1999): 1468–73. https://doi.org/10.1016/s0264-410x(98)00370-3.Full Text Link to Item
-
Walter, E. B., and D. A. Clements. “Travel consultation for children in a university-affiliated primary care setting.” Pediatr Infect Dis J 17, no. 9 (September 1998): 841–43. https://doi.org/10.1097/00006454-199809000-00021.Full Text Link to Item
-
Meine, E. K., S. R. Bailey, R. P. Drucker, D. A. Clements, and E. Walter. “Varicella vaccination in a primary care pediatric practice.” Arch Pediatr Adolesc Med 152, no. 6 (June 1998): 608–9.Link to Item
-
Rennels, M. B., M. J. Hohenboken, K. S. Reisinger, D. A. Clements, E. B. Walter, M. M. Blatter, J. Nonenmacher, and J. G. Hackell. “Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers.” Pediatr Infect Dis J 17, no. 2 (February 1998): 164–66. https://doi.org/10.1097/00006454-199802000-00019.Full Text Link to Item
-
Walter, E. B., M. A. Lampe, E. Livingston, and R. A. Royce. “How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits.” N C Med J 59, no. 2 (1998): 105–9.Link to Item
-
Walter, E., J. Sung, E. Kahn Meine, R. P. Drucker, and D. A. Clements. “Lack of effectiveness of a letter reminder for annual influenza immunization of asthmatic children.” Pediatr Infect Dis J 16, no. 12 (December 1997): 1187–88. https://doi.org/10.1097/00006454-199712000-00022.Full Text Link to Item
-
Walter, E. B., S. S. Simmons, C. L. Bland, and D. A. Clements. “Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine.” Pediatr Infect Dis J 16, no. 6 (June 1997): 626–27. https://doi.org/10.1097/00006454-199706000-00016.Full Text Link to Item
-
Combs, S. P., E. B. Walter, R. P. Drucker, and D. A. Clements. “Removing a major barrier to universal hepatitis B immunization in infants.” Arch Pediatr Adolesc Med 150, no. 1 (January 1996): 112–14. https://doi.org/10.1001/archpedi.1996.02170260116024.Full Text Link to Item
-
Clements, D. A., C. B. Armstrong, A. M. Ursano, M. M. Moggio, E. B. Walter, and C. M. Wilfert. “Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents.” Pediatr Infect Dis J 14, no. 10 (October 1995): 874–79. https://doi.org/10.1097/00006454-199510000-00011.Full Text Link to Item
-
Clements, D. A., L. Langdon, C. Bland, and E. Walter. “Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care.” Arch Pediatr Adolesc Med 149, no. 10 (October 1995): 1113–17. https://doi.org/10.1001/archpedi.1995.02170230067009.Full Text Link to Item
-
Jones, S. E., C. B. Armstrong, C. Bland, E. B. Walter, and D. A. Clements. “Varicella prevalence in day-care centers.” Pediatr Infect Dis J 14, no. 5 (May 1995): 404–5. https://doi.org/10.1097/00006454-199505000-00021.Full Text Link to Item
-
Walter, E. B., A. J. Elliott, A. N. Regan, R. P. Drucker, D. A. Clements, and C. M. Wilfert. “Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card.” Pediatr Infect Dis J 14, no. 5 (May 1995): 376–81. https://doi.org/10.1097/00006454-199505000-00008.Full Text Link to Item
-
Walter, E. B., S. L. Katz, and W. J. Bellini. “Measles immunity in HIV-infected children.” Pediatr Aids Hiv Infect 5, no. 5 (October 1994): 300–304.Link to Item
-
Walter, E. B., S. S. Simmons, and D. A. Clements. “Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine.” J Infect Dis 170, no. 4 (October 1994): 1050–51. https://doi.org/10.1093/infdis/170.4.1050.Full Text Link to Item
-
Walter, E. B., R. P. Drucker, and D. A. Clements. “A major barrier to universal hepatitis B immunization of infants.” Arch Pediatr Adolesc Med 148, no. 5 (May 1994): 538–39. https://doi.org/10.1001/archpedi.1994.02170050096023.Full Text Link to Item
-
Comeau, A. M., H. W. Hsu, M. Schwerzler, G. Mushinsky, E. Walter, L. Hofman, and G. F. Grady. “Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards.” J Pediatr 123, no. 2 (August 1993): 252–58. https://doi.org/10.1016/s0022-3476(05)81697-x.Full Text Link to Item
-
Walter, E. B., K. J. Weinhold, and C. M. Wilfert. “Enhanced p24 antigen detection in sera from human immunodeficiency virus-infected children.” Pediatr Infect Dis J 12, no. 1 (January 1993): 94–96. https://doi.org/10.1097/00006454-199301000-00019.Full Text Link to Item
-
Maxeiner, H. G., K. O. Habermehl, T. Grünewald, and B. Ruf. “HIV-1 sensitivity to zidovudine and clinical outcome.” Lancet 339, no. 8793 (March 7, 1992): 626–27.Link to Item
-
Tudor-Williams, G., M. H. St Clair, R. E. McKinney, M. Maha, E. Walter, S. Santacroce, M. Mintz, K. O’Donnell, T. Rudoll, and C. L. Vavro. “HIV-1 sensitivity to zidovudine and clinical outcome in children.” Lancet 339, no. 8784 (January 4, 1992): 15–19. https://doi.org/10.1016/0140-6736(92)90140-x.Full Text Link to Item
-
Walter, E. B., R. P. Drucker, R. E. McKinney, and C. M. Wilfert. “Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.” J Pediatr 119, no. 1 Pt 1 (July 1991): 152–55. https://doi.org/10.1016/s0022-3476(05)81057-1.Full Text Link to Item
-
MCKINNEY, R. E., E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, A. AUSTIN, and C. M. WILFERT. “CD-4+ LYMPHOCYTES IN CHILDREN UNDER 2-YEARS OLD - ESTABLISHMENT OF NORMAL VALUES IN A POPULATION AT RISK FOR HIV AND PROGNOSTIC APPLICATION TO INFECTED CHILDREN.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.Link to Item
-
MCKINNEY, R. E., E. NOZIK, E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, and C. M. WILFERT. “HEMATOLOGIC ABNORMALITIES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED CHILDREN AND NONINFECTED BUT HIV ANTIBODY POSITIVE CONTROLS.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.Link to Item
-
Walter, E. B., M. V. Moggio, R. P. Drucker, and C. M. Wilfert. “Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.” Pediatr Infect Dis J 9, no. 9 (September 1990): 632–35.Link to Item
-
Walter, E. B., R. E. McKinney, B. A. Lane, K. J. Weinhold, and C. M. Wilfert. “Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis.” J Pediatr 117, no. 2 Pt 1 (August 1990): 255–58. https://doi.org/10.1016/s0022-3476(05)80540-2.Full Text Link to Item
-
Walter, E. B., J. L. Gingras, and R. E. McKinney. “Systemic Torulopsis glabrata infection in a neonate.” South Med J 83, no. 7 (July 1990): 837–38. https://doi.org/10.1097/00007611-199007000-00027.Full Text Link to Item
-
McKinney, R. E., P. A. Pizzo, G. B. Scott, W. P. Parks, M. A. Maha, S. N. Lehrman, M. Riggs, J. Eddy, B. A. Lane, and S. C. Eppes. “Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.” J Pediatr 116, no. 4 (April 1990): 640–47. https://doi.org/10.1016/s0022-3476(05)81619-1.Full Text Link to Item
-
Walter, E. “Vertical transmission of Citrobacter diversus from mother to infant.” Pediatr Infect Dis J 7, no. 9 (September 1988): 675. https://doi.org/10.1097/00006454-198809000-00022.Full Text Link to Item
-
-
Other Articles
-
“Seroprevalence of human immunodeficiency virus infection at sentinel hospitals.” N Engl J Med, December 27, 1990. https://doi.org/10.1056/NEJM199012273232615.Full Text Link to Item
-
-
Conference Papers
-
Brady, Allison M., Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, and Gitika Panicker. “Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity.” In Hum Vaccin Immunother, 16:1802–7, 2020. https://doi.org/10.1080/21645515.2019.1706410.Full Text Link to Item
-
Edwards, J. M., N. Watson, C. Focht, C. Wynn, C. A. Todd, E. B. Walter, R. Phillips Heine, and G. K. Swamy. “Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.” In Infectious Diseases in Obstetrics and Gynecology, Vol. 2019, 2019. https://doi.org/10.1155/2019/5430493.Full Text
-
Fortner, Kimberly B., Kathryn M. Edwards, Karen R. Broder, Natalia Jimenez, Yuwei Zhu, Emmanuel B. Walter, Robert P. Heine, Pedro Moro, Jennifer L. Liang, and Geeta K. Swamy. “343: Reactogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women.” In American Journal of Obstetrics and Gynecology, 214:S193–94. Elsevier BV, 2016. https://doi.org/10.1016/j.ajog.2015.10.383.Full Text
-
Shaheen, A. W., T. Palker, E. B. Walter, J. A. Galanko, N. J. Shaheen, and R. J. Dolor. “Prescription medication sharing in primary care.” In Journal of General Internal Medicine, 19:197–197. BLACKWELL PUBLISHING INC, 2004.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.